Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Copellor Auto 80mg Pen Injection
Manufacturer/Marketed By : ELI LILLY AND COMPANY INDIA PVT LTD
$259.44 $225.72
Copellor auto 80mg Pen Injection contains an active component as ixekizumab. It is a prescription medication for certain inflammatory conditions, primarily moderate to severe plaque psoriasis and psoriatic arthritis. Severe...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
IXEKIZUMAB
Active Pharmaceutical Ingredient
Copellor Auto 80mg Pen Injection
259,44$
225,72$
Copellor auto 80mg Pen Injection contains an active component as ixekizumab. It is a prescription medication for certain inflammatory conditions, primarily moderate to severe plaque psoriasis and psoriatic arthritis. Severe plaque psoriasis is a chronic autoimmune skin condition characterized by thick, red, and scaly patches. At the same time, psoriatic arthritis is an inflammatory condition that affects the joints and is often associated with psoriasis. This medication belongs to a class of drugs called interleukin inhibitors. Copellor auto 80mg Pen Injection has been shown to have a rapid onset of action, with noticeable improvements in skin symptoms and joint pain often seen within the first few weeks of treatment. Copellor auto 80mg Pen Injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. This medication may increase the risk of infections. Therefore, it is generally not recommended to start treatment with this medication in individuals with active infections, including localized or systemic infections. Live vaccines should not be administered concurrently with Copellor auto 80mg Pen Injection. In individuals with a history of HBV infection, the virus may reactivate during or after treatment with the use o this medication. Close monitoring and appropriate management strategies are necessary in these cases.
Active Pharmaceutical Ingredient
Uses
• Plaque psoriasis
• Psoriatic arthritis
Benefits
The therapeutic effect of Copellor auto 80mg Pen Injection is the reduction of inflammation and improvement of symptoms in individuals with severe plaque psoriasis and psoriatic arthritis. By specifically targeting and blocking the action of interleukin-17A (IL-17A), this medication helps to modulate the immune response, leading to a decrease in skin inflammation, scaling, redness, and joint pain. This results in a visible improvement in the appearance of psoriatic skin lesions and a reduction in joint swelling, stiffness, and discomfort, ultimately enhancing the quality of life for patients affected by these conditions.
Side Effects
Side Effects:
Most Common Side Effects
• Nausea
• Vomiting
• Injection site reactions
• Upper respiratory tract infections
• Headache
Common Side Effects
• Infections
• Allergic reactions
• Inflammatory bowel disease (IBD)
• Hepatitis B virus (HBV) reactivation
• Depression or suicidal thoughts
How To Use
To use Copellor auto 80mg Pen Injection, follow the instructions provided by your healthcare provider or as indicated on the medication label. It is typically administered as an injection under the skin. The exact dosing and administration instructions may vary based on the specific condition being treated.
Safety Advice
• Breast Feeding: The safety of Copellor auto 80mg Pen Injection during breastfeeding is not well established, and it is recommended to exercise caution and consult with a healthcare professional before using this medication while breastfeeding.
• Alcohol: It is generally recommended to avoid consuming alcohol while taking Copellor auto 80mg Pen Injection. Alcohol can interact, with this medication, and potentially increase the risk of side effects.
• Liver: Copellor auto 80mg Pen Injection has not been reported to have a direct toxic effect on the liver. However, it's important to consider that individuals with pre-existing liver conditions or underlying liver diseases may have an increased risk of developing liver problems while using Copellor auto 80mg Pen Injection or other medication.
• Lungs: If you have a pre-existing lung condition or any concerns about the impact of Copellor auto 80mg Pen Injection on your respiratory health, it is crucial to discuss these concerns with your healthcare provider.
• Driving: Copellor auto 80mg Pen Injection may cause side effects that can impair driving ability and overall alertness. Common side effects include dizziness, headache, and tremors, affecting coordination and reaction time.
• Pregnancy: The safety of Copellor auto 80mg Pen Injection during pregnancy has not been established, and its use is generally not recommended.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.